Benedict MD - EnVVeno Medical Chief States
| NVNO Stock | USD 2.90 0.04 1.40% |
Insider
Benedict MD is Chief States of enVVeno Medical Corp
| Age | 68 |
| Address | 70 Doppler, Irvine, CA, United States, 92618 |
| Phone | 949 261 2900 |
| Web | https://www.envveno.com |
EnVVeno Medical Management Efficiency
The company has return on total asset (ROA) of (0.3182) % which means that it has lost $0.3182 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4939) %, meaning that it created substantial loss on money invested by shareholders. EnVVeno Medical's management efficiency ratios could be used to measure how well EnVVeno Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of March 2025, Return On Tangible Assets is likely to drop to -0.51. In addition to that, Return On Capital Employed is likely to grow to -0.53. At this time, EnVVeno Medical's Non Current Assets Total are very stable compared to the past year. As of the 21st of March 2025, Intangible Assets is likely to grow to about 781.6 K, while Total Assets are likely to drop about 23.9 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| BA Chemistry | Orthofix Medical | 63 | |
| Geoffrey Rose | Pulmonx Corp | 51 | |
| John Treace | Treace Medical Concepts | 53 | |
| Sri Radhakrishnan | Pulmonx Corp | N/A | |
| Daniel Owens | Treace Medical Concepts | 52 | |
| John McKune | Pulmonx Corp | 49 | |
| Ed Joyce | Axogen Inc | N/A | |
| Patrick Mercer | IRIDEX | 52 | |
| Gregory Davault | Axogen Inc | 56 | |
| Kendra Wong | LENSAR Inc | 45 | |
| Jaime Frias | Treace Medical Concepts | 62 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Lisa Paul | Pulmonx Corp | 61 | |
| Christopher Holland | Electromed | 55 | |
| Keith Simeone | STRATA Skin Sciences | N/A | |
| Michael Goodman | STRATA Skin Sciences | N/A | |
| Alan Connaughton | LENSAR Inc | 53 | |
| Lindsey Little | LivaNova PLC | N/A | |
| Leigh Salvo | IRIDEX | N/A | |
| Fuad Ahmad | IRIDEX | 55 | |
| Mark Quick | Orthofix Medical | N/A | |
Management Performance
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.32 |
enVVeno Medical Corp Leadership Team
Elected by the shareholders, the EnVVeno Medical's board of directors comprises two types of representatives: EnVVeno Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnVVeno. The board's role is to monitor EnVVeno Medical's management team and ensure that shareholders' interests are well served. EnVVeno Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnVVeno Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Cormack, Chief Officer | ||
| Craig Glynn, Treasurer CFO | ||
| Benedict MD, Chief States | ||
| Sandy Prietto, Vice Marketing | ||
| Robert Berman, CEO Director | ||
| Marc MD, Senior Officer | ||
| Hamed Alavi, Senior Officer | ||
| Warren Hancock, Cofounder |
EnVVeno Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EnVVeno Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | 8.06 M | ||||
| Shares Outstanding | 17.54 M | ||||
| Shares Owned By Insiders | 0.92 % | ||||
| Shares Owned By Institutions | 24.37 % | ||||
| Number Of Shares Shorted | 427.14 K | ||||
| Price To Book | 1.19 X | ||||
| EBITDA | (23.83 M) | ||||
| Net Income | (21.82 M) |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.